Krystal Biotech, Inc. · NASDAQ:KRYS
Vanguard Portfolio Management LLC reported a 5.05% stake in Krystal Biotech, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Portfolio Management LLC reported a 5.05% stake in Krystal Biotech, Inc., 1,479,111 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.05%
- Shares
- 1,479,111
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Portfolio Management | 5.05% | 1,479,111 |